Psyence Biomedical Ltd. PBM
3.18 USD +0.15 (+4.95%)
At closeNov 11, 2026, 6:37 PM EST
3.17 -0.01 -0.31%
After hours · Nov 11, 6:37 PM ET
3.07 Day range 3.29
1.92 52-week range 116.41
- YTD
- -89.19%
- 1 year
- -96.95%
News
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers NRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 12.0% to $2.98 during Friday's pre-market session. The market value of their outstanding shares is at $115.1 million. Intensity…
benzinga.com Psyence Biomedical Completes Its Additional Investment In PsyLabs Of $2,599,896 Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company") today announced that both milestones attached to its backstop subscription commitment in Psyence Labs Ltd. ("PsyLabs")
globenewswire.com Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that both milestones attached to its backstop subscription…
benzinga.com Psyence Biomedical Signs Manufacturing Services Agreement With DEA-Registered Benuvia For Planned U.S. Manufacture Of Pharmaceutical-Grade Ibogaine Active Pharmaceutical Ingredient Benuvia operates an 83,000-square-foot, DEA-registered controlled-substance manufacturing facility in Round Rock, Texas, with capabilities spanning development through commercial-scale…
globenewswire.com Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S. development program Partnership intended to establish a…
benzinga.com Psyence Biomedical Unit TIRC Signs Binding Term Sheet With Psyence Labs For An Exclusive License, Supply And Wholesale Distribution Arrangement For Psylabs’ Pharmaceutical-Grade Ibogaine In The U.S. The term sheet is binding on the parties and is to be superseded by a definitive agreement, which the parties have agreed to conclude on or before November 30, 2026; if a definitive agreement is not…
globenewswire.com Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation Binding term sheet with PsyLabs provides Psyence BioMed's Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs' pharmaceutical-grade ibogaine, subject to a…
benzinga.com Psyence Biomedical Agrees To Make Cash Investment Of Up To $5M In Psyence Labs Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchangeHighlightsThe Company is actively advancing plans for a potential…
globenewswire.com Psyence BioMed Announces Strategic Ibogaine Investment Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange Highlights The Company is actively advancing plans for a potential…
globenewswire.com Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development HIGHLIGHTS Texas-based company established as dedicated U.S. vehicle for regulated ibogaine development Positioned to hold U.S. rights to PsyLabs' pharmaceutical-grade ibogaine, subject to completion…
benzinga.com Modular Medical Secures National PBM Contract For Pivot Insulin Pump Commercial-stage medical device manufacturer Modular Medical Inc. (NASDAQ:MODD) recently signed a significant contract with a national U.S. pharmacy benefit manager (PBM).
globenewswire.com Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Company says growing federal commitment to…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 billion. bioAffinity…
businesswire.com Tredium Solutions Selected to Support Scripius' Pharmacy Benefits Platform MINNEAPOLIS--(BUSINESS WIRE)--Tredium Solutions, a provider of pharmacy benefit management (PBM) technologies, has been selected to support the administration of Scripius' commercial, Medicare, and…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com Psyence BioMed Establishes Active Ibogaine Operations, Production Capabilities In Africa Psyence BioMed Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research…
globenewswire.com Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com Prestige Consumer Healthcare Announces agreement To Acquire LaCorium Health, A Leader In Australian Therapeutic Skin Care For ~150M LaCorium AcquisitionThe Company today is also announcing a definitive agreement to acquire LaCorium Health ("LaCorium"), for approximately $150 million in cash. The transaction, subject to customary…
newsfilecorp.com Pacific Bay Adopts Semi-Annual Reporting Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") reports that the Company is adopting semi-annual financial…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order.html
globenewswire.com Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate across an expanded Australian site network Dosing initiates clinical evaluation of NPX-5, a…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Is Psyence Biomedical Stock Falling Wednesday? Psyence Biomedical faces a double-digit decline Tuesday as traders lock in gains following a massive 250% speculative rally last Thursday.
benzinga.com Why Is Psyence Biomedical Stock Trading Lower On Tuesday? Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump executive order and news on ibogaine supply.- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
feeds.benzinga.com PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-specific ibogaine supply catalyst.
benzinga.com PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-specific ibogaine supply catalyst.- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Psyence BioMed Builds Supply Pipeline For Psychedelic Drug Ibogaine As Demand Grows, Secures GMP-Grade Ibogaine Inventory To Support Research And Future Treatments Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psychedelic therapies and manufacturing…
globenewswire.com Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psychedelic…
benzinga.com Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $17 billion. Shares jump 20.2% to $493.01.- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 10 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Dow Jumps Over 600 Points; Netflix Shares Tumble After Q1 Results US stocks rise, Dow gains 600 points. NASDAQ up 1.05% and S&P 500 up 0.74%. Energy stocks down 4.5%. Netflix shares dip 11% on weak forecast.
benzinga.com Psyence BioMed Acknowledges U.S. Executive Order Plans To Evaluate Ibogaine's Therapeutic Potential Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies, today acknowledged…
globenewswire.com Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply Company highlights global leadership in GMP ibogaine manufacturing and commitment to…- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why Blaize Holdings Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winmate for edge AI deployments. Other gainers & losers.- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 'Trump To Sign Executive Order On Psychedelic Drug Used Abroad To Treat PTSD' - CBS News Exclusive https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
thenewswire.com Aurwest Resources Announces Execution of Definitive Agreement on Weaver Lake Gold Project Calgary, Alberta – TheNewswire - April 14, 2026 – Aurwest Resources Corporation (“ Aurwest ” or the “ Company ”) ( CSE: AWR ) is pleased to announce that the Company has entered into a Definitive…- benzinga.com Psyence BioMed Expands Australian Clinical Network To 5 Sites For Psilocybin Phase IIb Trial syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today…
globenewswire.com Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine…
defenseworld.net Head-To-Head Comparison: XBiotech (NASDAQ:XBIT) and Psyence Biomedical (NASDAQ:PBM) Psyence Biomedical (NASDAQ: PBM - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies…
globenewswire.com Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone “The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig “The strongest companies are built on the right foundations long before their…